Company intelligence / Profile preview

Global Neurohealth Ventures

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Global Neurohealth Ventures is a private, specialized impact venture capital firm focused on early-stage clinical neuroscience companies. The firm backs and supports startups developing breakthrough innovations for neurological and psychiatric disorders, positioning it at the intersection of healthcare investing and neuropsychiatric therapeutics. It appears to operate primarily as an investor rather than as a drug developer, manufacturer, or clinical-stage biopharma company. Publicly available information indicates the firm was founded in 2017 and is based in San Francisco, California, with leadership including Michael Cole and co-founder Roger Quy.

Therapeutic areas: PsychiatryNeurology
Industry: Investors

Beyond the preview

Go deeper on Global Neurohealth Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Global Neurohealth Ventures.

Explore the full profile